{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T14:47:44Z","timestamp":1783003664475,"version":"3.54.5"},"reference-count":31,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropediatrics"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          Background\u2003Autoimmune encephalitis (AE) is the third most common encephalitis in children. Diagnosis can be challenging due to overlapping and diverse clinical presentations as well as various investigation results. This study aims to characterize the clinical, diagnostic features, as well as treatment and outcomes of AE in children and determine the incidence of pediatric AE in Latvia.<\/jats:p><jats:p>\n          Methods\u2003The study was conducted at the Children's Clinical University Hospital in Riga. The study participants were patients under the age of 18 years diagnosed with AE from 2014 to 2022. Data regarding clinical characteristics, investigation findings, treatment strategy, and outcomes were retrospectively collected from the medical history data system.<\/jats:p><jats:p>\n          Results\u2003We included 18 pediatric patients diagnosed with AE. The mean incidence of pediatric AE in Latvia was 0.56 per 100,000 children. Most patients (66.6%) had seronegative AE. In the seropositive group, the most common was anti-methyl-D-aspartate receptor AE, with two patients having other antibodies. The most prevalent clinical features were personality change, cognitive impairment, autonomic dysfunction, and movement disorders. The majority of patients (58.8%) received first-line treatment only. More than half (55.6%) of our AE patient group had long-term sequelae.<\/jats:p><jats:p>\n          Conclusions\u2003Our study shows that the pediatric AE incidence in Latvia is similar to what has been previously reported in other studies. A relatively high proportion of seronegative AE was present in our cohort, indicating that awareness of possible misdiagnosis should be raised. Further research is needed to better understand the underlying mechanisms, characterize clinical features, and determine the treatment of choice in different situations to improve long-term outcomes.<\/jats:p>","DOI":"10.1055\/s-0044-1788259","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T22:46:35Z","timestamp":1721083595000},"page":"321-326","source":"Crossref","is-referenced-by-count":1,"title":["Pediatric Autoimmune Encephalitis: A Nationwide Study in Latvia"],"prefix":"10.1055","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7948-1825","authenticated-orcid":false,"given":"D.","family":"Pretkalnina","sequence":"additional","affiliation":[{"name":"Faculty of Doctoral Studies, Riga Stradins University, Riga, Latvia"},{"name":"Department of Neurosurgery and Neurology, Childrens Clinical University Hospital, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Grinvalde","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Riga Stradins University, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Kalnina","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Neurology, Childrens Clinical University Hospital, Riga, Latvia"},{"name":"Department of Pediatrics, Riga Stradins University, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,7,15]]},"reference":[{"issue":"01","key":"ref1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13052-022-01247-0","article-title":"Immune characteristics of children with autoimmune encephalitis and the correlation with a short-term prognosis","volume":"48","author":"J-Y Huang","year":"2022","journal-title":"Ital J Pediatr"},{"issue":"02","key":"ref2","doi-asserted-by":"crossref","first-page":"e663","DOI":"10.1212\/NXI.0000000000000663","article-title":"Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient","volume":"7","author":"T Cellucci","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"04","key":"ref3","first-page":"517","article-title":"Pediatric autoimmune encephalitis: practical aspects","volume":"15","author":"M R Ioghen","year":"2020","journal-title":"Maedica (Buchar)"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"646940","DOI":"10.3389\/fimmu.2021.646940","article-title":"Longitudinal CSF findings in autoimmune encephalitis\u2014a monocentric cohort study","volume":"12","author":"T Zrzavy","year":"2021","journal-title":"Front Immunol"},{"issue":"04","key":"ref5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"F Graus","year":"2016","journal-title":"Lancet Neurol"},{"issue":"06","key":"ref6","doi-asserted-by":"crossref","first-page":"e200148","DOI":"10.1212\/NXI.0000000000200148","article-title":"Mimics of autoimmune encephalitis","volume":"10","author":"R W Van Steenhoven","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"01","key":"ref7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jamaneurol.2022.4251","article-title":"Autoimmune encephalitis misdiagnosis in adults","volume":"80","author":"E P Flanagan","year":"2023","journal-title":"JAMA Neurol"},{"issue":"04","key":"ref8","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1212\/NXI.0000000000000130","article-title":"Earlier treatment of NMDAR antibody encephalitis in children results in a better outcome","volume":"2","author":"S Byrne","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"03","key":"ref9","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1212\/WNL.0000000000006783","article-title":"A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis","volume":"92","author":"R Balu","year":"2019","journal-title":"Neurology"},{"issue":"01","key":"ref10","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis","volume":"83","author":"D Dubey","year":"2018","journal-title":"Ann Neurol"},{"issue":"03","key":"ref11","doi-asserted-by":"crossref","first-page":"e682","DOI":"10.1212\/NXI.0000000000000682","article-title":"Pediatric autoimmune encephalitis: recognition and diagnosis","volume":"7","author":"M AAM de Bruijn","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3389\/fneur.2019.00906","article-title":"Pediatric autoimmune encephalitis: case series from two chinese tertiary pediatric neurology centers","volume":"10","author":"J Zhang","year":"2019","journal-title":"Front Neurol"},{"issue":"08","key":"ref13","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/ene.13661","article-title":"Syndrome and outcome of antibody-negative limbic encephalitis","volume":"25","author":"F Graus","year":"2018","journal-title":"Eur J Neurol"},{"issue":"06","key":"ref14","doi-asserted-by":"crossref","first-page":"e200170","DOI":"10.1212\/NXI.0000000000200170","article-title":"Antibody-negative autoimmune encephalitis: a single-center retrospective analysis","volume":"10","author":"H Moj\u017ei\u0161ov\u00e1","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"04","key":"ref15","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/ene.14139","article-title":"Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study","volume":"27","author":"M Gastaldi","year":"2020","journal-title":"Eur J Neurol"},{"issue":"01","key":"ref16","doi-asserted-by":"crossref","first-page":"e200182","DOI":"10.1212\/NXI.0000000000200182","article-title":"Antibody investigations in 2,750 children with suspected autoimmune encephalitis","volume":"11","author":"L-W Chen","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"01","key":"ref17","doi-asserted-by":"crossref","first-page":"e200218","DOI":"10.1212\/CPJ.0000000000200218","article-title":"Anti-NMDAR encephalitis clinical practice guideline: improving time to diagnosis, treatment, and hospital length of stay","volume":"14","author":"K M Barter","year":"2024","journal-title":"Neurol Clin Pract"},{"issue":"06","key":"ref18","doi-asserted-by":"crossref","first-page":"e20192543","DOI":"10.1542\/peds.2019-2543","article-title":"Infectious and autoimmune causes of encephalitis in children","volume":"145","author":"T A Erickson","year":"2020","journal-title":"Pediatrics"},{"issue":"03","key":"ref19","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s10072-020-04785-9","article-title":"HSV encephalitis triggered anti-NMDAR encephalitis: a case report","volume":"42","author":"S Hu","year":"2021","journal-title":"Neurol Sci"},{"issue":"09","key":"ref20","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1474-4422(18)30244-8","article-title":"Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis","volume":"17","author":"T Armangue","year":"2018","journal-title":"Lancet Neurol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"605042","DOI":"10.3389\/fped.2021.605042","article-title":"Clinical characteristics and prognostic factors of children with anti-N-methyl-D-aspartate receptor encephalitis","volume":"9","author":"S Yang","year":"2021","journal-title":"Front Pediatr"},{"issue":"05","key":"ref22","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1212\/01.WNL.0000113749.77217.01","article-title":"Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer","volume":"62","author":"L Bataller","year":"2004","journal-title":"Neurology"},{"issue":"01","key":"ref23","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12883-020-01788-z","article-title":"Rhombencephalitis associated with isolated Zic4-antibodies in paraneoplastic cerebellar degeneration: a case report","volume":"20","author":"P A Loehrer","year":"2020","journal-title":"BMC Neurol"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3988\/jcn.2016.12.1.1","article-title":"The diagnosis and treatment of autoimmune encephalitis","volume":"12","author":"E Lancaster","year":"2016","journal-title":"J Clin Neurol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"834929","DOI":"10.3389\/fneur.2022.834929","article-title":"Abnormal brain MRI findings in anti-N-methyl-D-aspartate receptor encephalitis and correlation with outcomes","volume":"13","author":"C Lei","year":"2022","journal-title":"Front Neurol"},{"issue":"08","key":"ref26","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00415-015-7781-9","article-title":"Treatment and outcome of children and adolescents with N-methyl-D-aspartate receptor encephalitis","volume":"262","author":"A Zekeridou","year":"2015","journal-title":"J Neurol"},{"issue":"01","key":"ref27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s40674-018-0089-z","article-title":"An update on the treatment of pediatric autoimmune encephalitis","volume":"4","author":"C Stingl","year":"2018","journal-title":"Curr Treatm Opt Rheumatol"},{"issue":"05","key":"ref28","doi-asserted-by":"crossref","first-page":"e1052","DOI":"10.1212\/NXI.0000000000001052","article-title":"International consensus recommendations for the treatment of pediatric NMDAR antibody encephalitis","volume":"8","author":"M Nosadini","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"09","key":"ref29","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1111\/epi.17327","article-title":"Second-line immunotherapy and functional outcomes in autoimmune encephalitis: a systematic review and individual patient data meta-analysis","volume":"63","author":"A Halliday","year":"2022","journal-title":"Epilepsia"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1756285617722347","DOI":"10.1177\/1756285617722347","article-title":"Treatment strategies for autoimmune encephalitis","volume":"11","author":"Y-W Shin","year":"2017","journal-title":"Ther Adv Neurol Disord"},{"issue":"18","key":"ref31","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1212\/WNL.0000000000002635","article-title":"Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort","volume":"86","author":"W-J Lee","year":"2016","journal-title":"Neurology"}],"container-title":["Neuropediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1788259.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T15:01:29Z","timestamp":1730818889000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1788259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,15]]},"references-count":31,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2024,9,9]]},"published-print":{"date-parts":[[2024,10]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1788259","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0174-304X","1439-1899"],"issn-type":[{"value":"0174-304X","type":"print"},{"value":"1439-1899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,15]]}}}